Voices from the front lines, founder of PsyPAN, Psychedelic Participant Action Network, Ian Rollier is interviewed by EURACTIVE on the transformative process of the innovative mental health treatments, therapeutic value and the effects of psilocybin on depression.
Behind the scenes of psychedelic trials: Participant's perspective
Previous
Previous
PAREA presents at MAPS Psychedelic Science
Next
Next

